AI drug discovery’s expensive reality
Rising compute costs have biotech firms rethinking how they use large language models.
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
Rising compute costs have biotech firms rethinking how they use large language models.
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
From fertility and menopause to sleep and recovery, Oura is building one of the largest consumer health datasets focused on women.
This week on Lifers, Christina Farr sits down with Chris Altchek, who went from investment banking to building Mic, a digital media company that reached 100 million readers, before co-founding Cadence, a health tech company now managing nearly 100,000 chronic disease patients per day.
Plus: updates on the Ebola outbreak, CMS' prior authorization program, and Healthcare.gov
In this episode of Lifers, Christina Farr sits down with Heather Fernandez, CEO of Solv and former Trulia executive, to dig into the question that has stumped healthcare for decades: why don't patients know what their doctor visit will cost?
"Automation Bias in LLM-Assisted Diagnostic Reasoning Among AI-Trained Physicians"
Here’s what employers are likely to do about it...
In this special episode of Lifers, Christina Farr sits down with Dr. Rian Kabir, a psychiatrist and medical AI expert, to discuss the mental health implications of Kalshi's $22 billion valuation.
Plus all the most important news of the week!
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.